|
Contents
|
|
|
|
Glioblastoma
|
|
|
|
G.
J. Lesser, K. Carson, J. Supko, J. Kuhn, R. Priet, B. Nabors, D. Lawson, T.
Doyle, S. Grossman
A
phase I/II trial and pharmacokinetic study of pyrazoloacridine in adults with
newly diagnosed glioblastoma multiforme
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
485
|
|
Glenn
J Lesser, Kit Carson, Regina Priet, L. B Nabors, Thomas Doyle, Stuart A
Grossman
A
phase I/II trial of pyrazoloacridine (PZA) in adults with newly diagnosed
glioblastoma multiforme (GBM)
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No. 2097
|
|
|
Neuroblastoma
|
|
|
|
Nino Keshelava, Denice Tsao-Wei and C.
Patrick Reynolds
Pyrazoloacridine Is Active in Multidrug-resistant Neuroblastoma Cell Lines
with Nonfunctional p53
Clinical Cancer Research Vol. 9, 3492-3502, August 2003. (PDF Full Text)
|
|
|
|
